These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7592640)

  • 21. Identification and purification of the Holo-ELL complex. Evidence for the presence of ELL-associated proteins that suppress the transcriptional inhibitory activity of ELL.
    Shilatifard A
    J Biol Chem; 1998 May; 273(18):11212-7. PubMed ID: 9556611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau.
    Goode BL; Feinstein SC
    J Cell Biol; 1994 Mar; 124(5):769-82. PubMed ID: 8120098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription initiated by RNA polymerase II and purified transcription factors from liver. Transcription factors alpha, beta gamma, and delta promote formation of intermediates in assembly of the functional preinitiation complex.
    Conaway RC; Conaway JW
    J Biol Chem; 1990 May; 265(13):7559-63. PubMed ID: 1692022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissection of transcription factor TFIIF functional domains required for initiation and elongation.
    Tan S; Conaway RC; Conaway JW
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6042-6. PubMed ID: 7597077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II.
    Reines D
    J Biol Chem; 1992 Feb; 267(6):3795-800. PubMed ID: 1371280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA polymerase II elongation complex. Elongation complexes purified using an anti-RNA antibody do not contain initiation factor alpha.
    Reines D
    J Biol Chem; 1991 Jun; 266(16):10510-7. PubMed ID: 1709935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription elongation by RNA polymerase II: mechanism of SII activation.
    Reines D; Ghanouni P; Gu W; Mote J; Powell W
    Cell Mol Biol Res; 1993; 39(4):331-8. PubMed ID: 8312968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elongation properties of vaccinia virus RNA polymerase: pausing, slippage, 3' end addition, and termination site choice.
    Deng L; Shuman S
    Biochemistry; 1997 Dec; 36(50):15892-9. PubMed ID: 9398322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.
    Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA
    J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.
    Krumm A; Hickey LB; Groudine M
    Genes Dev; 1995 Mar; 9(5):559-72. PubMed ID: 7698646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model for the mechanism of bacteriophage T7 RNAP transcription initiation and termination.
    Sousa R; Patra D; Lafer EM
    J Mol Biol; 1992 Mar; 224(2):319-34. PubMed ID: 1560455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription initiated by RNA polymerase II and transcription factors from liver. Structure and action of transcription factors epsilon and tau.
    Conaway JW; Hanley JP; Garrett KP; Conaway RC
    J Biol Chem; 1991 Apr; 266(12):7804-11. PubMed ID: 2019603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA polymerase II transcription factor SIII. I. Identification, purification, and properties.
    Bradsher JN; Jackson KW; Conaway RC; Conaway JW
    J Biol Chem; 1993 Dec; 268(34):25587-93. PubMed ID: 8244996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of inhibition of bacteriophage T7 RNA polymerase by T7 lysozyme.
    Zhang X; Studier FW
    J Mol Biol; 1997 May; 269(1):10-27. PubMed ID: 9192997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription initiated by RNA polymerase II and purified transcription factors from liver. Cooperative action of transcription factors tau and epsilon in initial complex formation.
    Conaway JW; Reines D; Conaway RC
    J Biol Chem; 1990 May; 265(13):7552-8. PubMed ID: 2332442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RNA polymerase II general elongation factors.
    Reines D; Conaway JW; Conaway RC
    Trends Biochem Sci; 1996 Sep; 21(9):351-5. PubMed ID: 8870500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Footprinting analysis of mammalian RNA polymerase II along its transcript: an alternative view of transcription elongation.
    Rice GA; Kane CM; Chamberlin MJ
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4245-9. PubMed ID: 1709738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription on nucleosomal templates by RNA polymerase II in vitro: inhibition of elongation with enhancement of sequence-specific pausing.
    Izban MG; Luse DS
    Genes Dev; 1991 Apr; 5(4):683-96. PubMed ID: 2010092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
    Shilatifard A; Haque D; Conaway RC; Conaway JW
    J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.